Accurate diagnosis is the foundation of effective prostate cancer treatment. Traditional prostate biopsies rely on random tissue sampling, which may miss aggressive cancers or lead to unnecessary repeat procedures. UroNav fusion biopsy has changed the standard by combining MRI and ultrasound for highly targeted results.
Here’s how it works: an MRI scan first identifies suspicious areas within the prostate. These images are then fused with real-time ultrasound guidance during the biopsy. This allows the urologist to precisely target problem spots, improving both accuracy and efficiency.
The benefits of UroNav are significant. By focusing only on areas that appear abnormal, unnecessary tissue sampling is reduced. This lowers the risk of complications and increases the likelihood of detecting clinically significant cancers. It also reduces the number of men who undergo repeat biopsies due to inconclusive results.
For patients, this means fewer uncertainties and more confidence in their diagnosis. Knowing exactly where cancer is and how aggressive it may be helps doctors design treatment plans that are tailored to each individual’s condition.
UroNav fusion biopsy is especially valuable for men with elevated PSA levels but previously negative biopsies. In these cases, traditional methods may have missed important areas. With fusion technology, the chance of finding hidden cancer increases.
This advanced approach demonstrates the importance of precision in modern urology. By integrating imaging with diagnostic procedures, UroNav fusion biopsy provides men with clearer answers and better treatment options.
If you have elevated PSA levels or concerns about prostate health, ask your urologist about UroNav fusion biopsy and how it can give you the most accurate results.
Quick Links
